Biowaiver for lower strength [Study Per­for­mance]

posted by luvblooms  – India, 2021-08-18 12:34 (1421 d 21:54 ago) – Posting: # 22527
Views: 3,793

Hi Vishal

❝ clarification-after in vitro testing, the 2.5mg strength does not show proportional similarity and acceptable in vitro dissolution testing.


A common problem with drugs that have dose-dependent solubility.
The best way to handle this scenario is to go with does equivalent dissolution approach (assuming your formulation is dose-proportional).

Example:

2.5 mg *8 vs 20 mg
5 mg*4 vs 20
10mg *2 vs 20

There are few SBoA's available where FDA has recommended this approach.
I am trying to find those and will update the post if I am able to get those.

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,685 registered users;
50 visitors (0 registered, 50 guests [including 11 identified bots]).
Forum time: 10:28 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5